drugset / Trial / NCT05277415

Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure

NCT05277415

Phase 1/2 Completed 31 enrolled Lars Lund
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In patients with HF cardiac output, metabolism and endothelial function will be studied during and after treatment with ghrelin infusion

Timeline

Start
2013-02-17
Primary completion
2014-05-22
Completion
2014-05-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ghrelin Peptide 30 unknown Intravenous

Indications